Objectives: This study was intended to describe and correlate the neuroimaging findings in pediatric patients after sepsis. Design: Retrospective chart review. Setting: Single tertiary care PICU. Patients: Patients admitted to Cincinnati Children's Hospital Medical Center with a discharge diagnosis of sepsis or septic shock between 2004 and 2013 were crossmatched with patients who underwent neuroimaging during the same time period. Interventions: All neuroimaging studies that occurred during or subsequent to a septic event were reviewed, and all new imaging findings were recorded and classified. As many patients experienced multiple septic events and/or had multiple neuroimaging studies after sepsis, our statistical analysis utilized the most recent or "final" imaging study available for each patient so that only brain imaging findings that persisted were included.
S epsis is a heterogeneous syndrome resulting from the response of the immune system to invasive infection. When accompanied by organ system dysfunction or hypoperfusion, severe sepsis or septic shock occur and are a leading cause of morbidity and mortality in critically ill patients (1, 2) . Sepsis is often accompanied by an acute encephalopathy which, when present, worsens prognosis (3, 4 3, 6 ; Hector R. Wong, MD 2 *See also p. 716. 1 impairment has been described in the adult literature as a common sequela of surviving critical illness, most notably sepsis (5, 6) . Additionally, various patterns of brain imaging findings have been described in adult patients with acute sepsis and include cytotoxic edema, vasogenic edema, posterior reversible encephalopathy syndrome, white matter disruption, and brain atrophy (7) (8) (9) (10) .
Exploration of short-and long-term cognitive outcomes after pediatric critical illness is limited to date. In 2004, a Londonbased group of investigators demonstrated that children admitted to the PICU were more likely to demonstrate posttraumatic stress disorder symptomatology compared with ward-matched controls (11) . In a pilot study from 2008, the same group demonstrated impaired memory and attention in children following critical illness, most notably in patients with sepsis (12) . A 2009 single-center study in the Netherlands demonstrated significantly lower cognitive function in survivors of pediatric sepsis, particularly in those who experienced sepsis at a younger age (13) . Most recently, two prospective case-control studies demonstrated that admission to the PICU was associated with decreased educational and neuropsychologic performances, particularly following meningoencephalitis and sepsis (14) and that children with sepsis-associated encephalopathy have cognitive impairment and poor academic performance at short-term follow-up (15) . Although these studies provide data to corroborate that similar to adults, neurocognitive impairment occurs after pediatric critical illness, these data remain limited.
Neuroimaging findings during or after sepsis have not been described in pediatric patients. Given the immaturity of the pediatric brain relative to adults, it is plausible that neuroanatomic abnormalities occur frequently after pediatric sepsis. The purpose of this study was to describe and correlate the neuroimaging findings in pediatric patients after sepsis.
MATERIALS AND METHODS
Following institutional review board approval, we obtained a crossmatched list of patients admitted to Cincinnati Children's Hospital Medical Center PICU between 2004 and 2013 with a diagnosis of sepsis or septic shock who also underwent head CT or brain MRI during the same time period. Patients were identified from an institutional critical care database as having sepsis or septic shock as documented by an attending physician at any point during their PICU hospitalization. Patients who experienced sepsis and underwent neuroimaging either during or subsequent to a septic event were included in the study. For patients who experienced multiple septic episodes or had multiple neuroimaging studies during the study period, multiple data entries were included.
Using the electronic medical record, data were collected regarding demographics, comorbidities, illness severity as indicated via Pediatric Risk of Mortality (PRISM)-III score, and the indications for each neuroimaging study. Imaging findings were reviewed, and abnormalities were identified via the explicit language employed in the written report by the original radiologist reading the study. If imaging findings in the original written report were unclear or required further evaluation, neuroimaging studies were rereviewed by a study radiologist for clarification (n = 89).
Data extraction was performed by a single reviewer to identify patterns of neuroimaging findings and only those new (not known to be chronic) imaging findings were recorded and classified. As many patients experienced multiple septic events and/or had multiple neuroimaging studies after sepsis, descriptive data are grouped into all imaging studies as well as final imaging studies, defined as the most recent imaging study available for a given patient.
A multivariable logistic regression model was used to test for associations between clinical variables and abnormal findings on final neuroimaging. The independent clinical variables explored were those felt to potentially influence the neuroimaging abnormalities identified and included a diagnosis of meningitis/encephalitis (determined via International Classification of Diseases, 9th Edition coding as detailed in Supplemental Table 1 , Supplemental Digital Content 1, http:// links.lww.com/PCC/A415), presence of preexisting neurologic disease, presence of an oncologic diagnosis/prior organ transplantation, frequency of sepsis episodes, age at first sepsis, highest PRISM-III score, and "early" (0-14 d) versus "late" (˃ 14 d) neuroimaging timing following the first sepsis episode. Initially, all variables were included in the logistic regression analysis as all were felt to be relevant to the outcomes investigated; ultimately, those variables found to be insignificant were removed to achieve the most parsimonious model. Statistical power was sufficient to perform multivariable logistic regression for the following outcomes: all abnormal findings, volume loss, MRI signal and/or CT attenuation abnormality, and fluid collection/hemorrhage. Data are presented as odds ratios for individual predictors with 95% CIs. Statistics were performed using SigmaPlot 13.0 (Systat Software, San Jose, CA) and SPSS Statistics Version 22 (IBM, Armonk, NY).
RESULTS
A total of 800 children were identified as having sepsis or septic shock during the study period. Three hundred eighty-nine children underwent concurrent or subsequent neuroimaging and were therefore included in the study (Fig. 1) . A total of 1,705 neuroimaging studies for those 389 patients were reviewed. Median age at first septic event was 3.4 years (interquartile range, 0.7-11.5). Median time from first sepsis to final neuroimaging was 157 days (interquartile range, 10-1,054). Demographic data for the included cohort are provided in Table 1 , and it should be noted that some patients experienced multiple medical comorbidities. Table 2 shows the indications for neuroimaging. The three most common indications for all neuroimaging studies were follow-up (29%), altered mental status (16%), and seizures (13%). The three most common indications for final neuroimaging were follow-up (21%), altered mental status (18%), and fever/concern for infection (15%).
The distribution of neuroimaging studies per time period following the first septic episode is depicted in Figures 2 and 3 . For both groups of all neuroimaging studies and final neuroimaging studies, the time period during which the most neuroimaging studies were performed was within 14 days of the first septic episode. Table 3 shows the abnormalities categorized via review of the neuroimaging studies. Sixty-three percentage of all neuroimaging studies demonstrated abnormal findings. The most common of these were volume loss (27%), MRI signal and/or CT attenuation abnormality (20%), fluid collection/hemorrhage (17%), enlarged ventricles (14%), cerebral edema (7%), and encephalomalacia (5%). Similarly, 63% of final imaging studies demonstrated abnormal findings, the most common of which were also volume loss (39%), MRI signal and/or CT attenuation abnormality (21%), fluid collection/hemorrhage (13%), enlarged ventricles (8%), encephalomalacia (6%), and cerebral edema (6%). Given the high incidence of neuroimaging studies obtained within 14 days of the first septic event, the incidence of neuroimaging abnormalities categorized as early (occurring within 14 d of the first septic event) versus late (occurring > 14 d after the first septic event) are further delineated in Table 3 . Table 4 further describes the MRI signal and/or CT attenuation abnormality data. Of the 80 final imaging studies with identified abnormalities, the most common were MRI T2 hyperintense signal abnormalities (n = 46), MRI fluid-attenuated inversion recovery hyperintense signal abnormalities (n = 40), and CT hypodensities (n = 30). The most commonly involved structures that demonstrated such abnormalities were white matter (n = 71) and cerebral cortex (n = 35). The majority of abnormalities were found bilaterally (87.5%) but did not cause mass effect (12.5%). Most final imaging studies to demonstrate MRI signal or CT attenuation abnormalities had greater than or equal to four abnormalities (67.5%), the largest of which were 1-4 cm in size (40%) or greater than or equal to 4 cm (36.3%).
Of the 389 patients, 46% (n = 178) had preexisting neurologic conditions. Thirty-four percentage (n = 134) had an oncologic diagnosis or had received an organ transplant. In contrast, only 5% (n = 19) had a diagnosis of meningitis and/or encephalitis during any septic event. All variables were included in the logistic regression analysis. Table 5 shows the results of our multivariable logistic regression analysis of abnormal final neuroimaging findings. Higher PRISM score and the presence of an oncologic disease/organ transplantation were independently associated with any abnormal final neuroimaging study findings (p = 0.048 and p = 0.041, respectively). Early timing of neuroimaging was found to decrease the odds of demonstrating any abnormal final neuroimaging (p = 0.039). Number of sepsis episodes demonstrated no significant association. The most common abnormal finding of volume loss on the final neuroimaging study was independently associated with both higher PRISM score (p = 0.016) and the presence of an oncologic diagnosis/organ transplantation (p = 0.001). Early timing of neuroimaging was found to decrease the odds of demonstrating volume loss on final neuroimaging (p = 0.037). For the second most common abnormal finding of MRI signal and/or CT attenuation abnormality, early timing of neuroimaging was similarly found to decrease the odds of this outcome (p = 0.010). 
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DISCUSSION
This study describes the neuroimaging findings of a large population of pediatric patients following one or more episodes of sepsis. Given that the median duration between the first sepsis episode and final neuroimaging was 157 days, this study captures relatively long-term neuroanatomic changes that occur following pediatric sepsis. It is noteworthy that the majority of patients (63%) who experienced sepsis and concurrently or subsequently underwent neuroimaging had abnormal final neuroimaging findings. The most common of these abnormalities was volume loss, which was documented in 39% of the studied patient population and was independently associated with the presence of an oncologic diagnosis/ organ transplant and higher severity of sepsis as measured by PRISM score. The positive association of oncologic diagnosis/ organ transplantation with this finding is not surprising, given that the therapies associated with such diagnoses are known to cause brain atrophy. However, it is important to note that this association did not diminish the effect of higher illness severity on this outcome. Furthermore, a considerable proportion of patients had numerous, large, bilateral MRI signal and/or CT attenuation abnormalities in the cerebral cortex and white matter. This study clearly documents that the majority of pediatric PICU patients with sepsis or septic shock and concurrent or subsequent neuroimaging have abnormal brains. Although beyond the scope of this retrospective analysis, this high burden of neuroimaging abnormalities has implications for longterm neurocognitive outcomes. The effect of timing of neuroimaging on outcomes also warrants discussion. The largest number of neuroimaging studies were performed within 14 days of the first septic episode. However, the decreased odds of demonstrating any abnormality, volume loss, or MRI signal and/or CT attenuation abnormality for studies during this early period indicates that those performed more than 14 days after the first septic episode are more likely to demonstrate such abnormalities. This not only points to this study's capture of long-term neuroanatomic changes after sepsis but also that such abnormalities develop over time and again speaks to the implication for long-term neurocognitive outcomes.
The patient population examined in this study demonstrates a high proportion of preexisting neurologic conditions (46%) and oncologic diagnoses/organ transplantations (34%). This is not surprising, given that this study captures those patients who experienced sepsis or septic shock and underwent neuroimaging, as patients with such preexisting diagnoses are more likely to undergo brain imaging as part of routine followup. Exploration of the patient population who experienced sepsis but did not undergo neuroimaging is clearly beyond the breadth of this study, given its retrospective structure, but certainly provokes some questioning. There are several limitations to this study, most notably our inability to control for all concurrent conditions in this patient population, which likely contribute to the abnormal neuroimaging findings described. Although this study demonstrated no correlation between preexisting neurologic conditions or a diagnosis of meningitis/encephalitis and abnormal neuroimaging findings as a whole or the most commonly documented abnormalities, this study was not able to fully account for the heterogeneity of the patient population at this large, tertiary care medical center. Therefore, we cannot conclude that sepsis is causative of all neuroimaging abnormalities found in this study.
Further, although this study attempted to capture only "new" neuroimaging findings that were not known to be chronic, not all included patients had prior imaging studies to demonstrate previous absence of abnormalities. Therefore, some neuroanatomic abnormalities may be falsely categorized as new.
Finally, both brain MRI and head CT imaging findings were included for the patient population studied. Given the higher contrast resolution provided by brain MRI when compared with CT imaging, some subtle abnormalities may be underestimated in those patients who underwent head CT imaging alone.
CONCLUSIONS
Despite these limitations, this study describes abnormalities of the pediatric brain after sepsis in a relatively large cohort, generalizable to patients seen at large tertiary care centers. Although sepsis is not solely causative of the many abnormalities noted in this study, it is, at least, potentially contributory, and this high incidence of abnormalities warrants further exploration.
